294 related articles for article (PubMed ID: 37170010)
1. Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes.
Malayil R; Chhichholiya Y; Vasudeva K; Singh HV; Singh T; Singh S; Munshi A
Med Oncol; 2023 May; 40(6):174. PubMed ID: 37170010
[TBL] [Abstract][Full Text] [Related]
2. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
4. PI3K signaling-regulated metabolic reprogramming: From mechanism to application.
Su WY; Tian LY; Guo LP; Huang LQ; Gao WY
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188952. PubMed ID: 37499988
[TBL] [Abstract][Full Text] [Related]
5. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
6. The Warburg Effect: Historical Dogma Versus Current Rationale.
Vaupel P; Multhoff G
Adv Exp Med Biol; 2021; 1269():169-177. PubMed ID: 33966213
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
8. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic regulation of tumor metabolic reprogramming.
Tarrado-Castellarnau M; de Atauri P; Cascante M
Oncotarget; 2016 Sep; 7(38):62726-62753. PubMed ID: 28040803
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
Lien EC; Lyssiotis CA; Cantley LC
Recent Results Cancer Res; 2016; 207():39-72. PubMed ID: 27557534
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming of immune cells in pancreatic cancer progression.
Xiang H; Yang R; Tu J; Xi Y; Yang S; Lv L; Zhai X; Zhu Y; Dong D; Tao X
Biomed Pharmacother; 2023 Jan; 157():113992. PubMed ID: 36395610
[TBL] [Abstract][Full Text] [Related]
12. Canagliflozin, a SGLT-2 inhibitor, relieves ER stress, modulates autophagy and induces apoptosis in irradiated HepG2 cells: Signal transduction between PI3K/AKT/GSK-3β/mTOR and Wnt/β-catenin pathways;
Abdel-Rafei MK; Thabet NM; Rashed LA; Moustafa EM
J Cancer Res Ther; 2021; 17(6):1404-1418. PubMed ID: 34916371
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
14. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
[TBL] [Abstract][Full Text] [Related]
15. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.
Courtnay R; Ngo DC; Malik N; Ververis K; Tortorella SM; Karagiannis TC
Mol Biol Rep; 2015 Apr; 42(4):841-51. PubMed ID: 25689954
[TBL] [Abstract][Full Text] [Related]
16. Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade.
Lue HW; Podolak J; Kolahi K; Cheng L; Rao S; Garg D; Xue CH; Rantala JK; Tyner JW; Thornburg KL; Martinez-Acevedo A; Liu JJ; Amling CL; Truillet C; Louie SM; Anderson KE; Evans MJ; O'Donnell VB; Nomura DK; Drake JM; Ritz A; Thomas GV
Genes Dev; 2017 Oct; 31(20):2067-2084. PubMed ID: 29138276
[TBL] [Abstract][Full Text] [Related]
17. The ERK and JNK pathways in the regulation of metabolic reprogramming.
Papa S; Choy PM; Bubici C
Oncogene; 2019 Mar; 38(13):2223-2240. PubMed ID: 30487597
[TBL] [Abstract][Full Text] [Related]
18. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
[TBL] [Abstract][Full Text] [Related]
19. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
Chhichholiya Y; Ruthuparna M; Velagaleti H; Munshi A
Clin Transl Oncol; 2023 May; 25(5):1218-1241. PubMed ID: 36897508
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells.
Chiavarina B; Martinez-Outschoorn UE; Whitaker-Menezes D; Howell A; Tanowitz HB; Pestell RG; Sotgia F; Lisanti MP
Cell Cycle; 2012 Sep; 11(17):3280-9. PubMed ID: 22894905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
